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Abstract
Background: Transcutaneous electric acupoint stimulation (TEAS) avoids the use of needles, and instead delivers a
mild electric current at traditional acupoints. This technique has been used for treating heroin addiction, but has
not been systematically tested for other drugs of abuse. This study aims to investigate the effects of TEAS on drug
addiction.
Methods: Volunteers who were either cocaine-dependent (n=9) or cannabis-dependent (n=11) but were not
seeking treatment for their dependence participated in a within-subject, single-blind study. Treatment consisted of
twice daily 30-minute sessions of TEAS or sham stimulation for 3.5 days. The active TEAS levels were individually
adjusted to produce a distinct twitching response in the fingers, while the sham stimulation involved 2 minutes of
stimulation at threshold levels followed by 28 minutes of stimulation below the detection levels. The participants
recorded their drug use and drug cravings daily. At 1 hour after the last morning session of TEAS or sham
stimulation, a cue-induced craving EEG evaluation was conducted. Event-related P300 potentials (ERPs) were
recorded, sorted, and analyzed for specific image types (neutral objects, non-drug-related arousing images, or drug-
related images).
Results: TEAS treatment did not significantly reduce the drug use or drug cravings, or significantly alter the ERP
peak voltage or latency to peak response. However, the TEAS treatment did significantly modulate several self-
reported measures of mood and anxiety.
Conclusion: The results of this pilot study with a limited sample size suggest that the acupoint stimulation
techniques and protocol used in this trial alone do not significantly reduce cravings for or use of cocaine or
cannabis. The findings that TEAS modulates mood and anxiety suggest that TEAS could be used as an adjunct in a
multimodal therapy program to treat cocaine and cannabis dependence if confirmed in a full randomized
controlled clinical trial.
Background
Drug abuse and dependence are medical problems that
have impacts on the personal, social, and economic fab-
ric of society. Searches for effective therapies have been,
and continue to be, important areas of research in
neuroscience and pharmacology, as these disciplines
seek to develop a greater understanding of the biological
basis of drug abuse. Although there are several approved
interventions for treating tobacco, alcohol, and opioid
addiction, there remains a lack of effective medical treat-
ments for cocaine and cannabis abuse.
Traditional acupuncture methods involving the inser-
tion of needles at specific points on the body have been
used for centuries to treat a variety of maladies [1]. A re-
view of controlled clinical trials by the World Health
Organization has documented that drug dependence
(specifically alcohol, cocaine, opiates/heroin, and tobacco
dependence) is a condition for which acupuncture may
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ranted [2]. Owing to the widespread use of acupuncture
techniques to treat abuse problems related to alcohol,
nicotine, and opiates, numerous researchers have
attempted to systematically assess its usefulness in treat-
ing cocaine abuse. Most commonly, auricular acupunc-
ture techniques (involving needle insertion at specific
locations on the outer ear) have been tested with mixed
results [3-6]. Although a well-controlled study on
methadone-maintained cocaine-dependent subjects
showed a significant decrease in cocaine-positive urine
samples after 8 weeks of treatment [4], a larger-scale
study by the same research group concluded that acu-
puncture was no better than a needle-insertion control
condition or a relaxation control condition in these
dually-dependent subjects [7]. Two systematic reviews of
the available literature concluded that the currently
available acupuncture techniques are not effective in
treating cocaine abuse [8,9].
Alternative strategies involve application of electrical
stimulation to needles inserted into traditional acupunc-
ture points or simply application of electrical stimulation
via electroconductive pads on the skin at these acu-
points. These techniques have been found to be effective
in reducing the severity of heroin withdrawal symptoms
[10] and relapse [11]. Evidence for the possible effective-
ness of these techniques for cocaine dependence may be
inferred from an animal study, which showed that
cocaine-induced conditioned place preference in rats
was blocked by application of electroacupuncture at
100 Hz, but not at 2 Hz [12]. Neither traditional needle
insertion nor electrical stimulation has been assessed in
cocaine- and cannabis-dependent individuals.
Transcutaneous electric acupoint stimulation (TEAS)
has been shown to promote the release of endorphins
[1], which may be the basis of its effectiveness for opiate
addiction, and also lead to the release of a variety of neu-
ropeptides that control important brain functions [13].
This study aims to explore the feasibility of TEAS as a
possible means for reducing drug use and drug cravings
in cocaine- and cannabis-dependent subjects.
Methods
Participants
Cocaine- and cannabis-dependent individuals who were
not seeking treatment for their dependence were
recruited by advertisements in local newspapers and on
the internet. The protocol and informed consent forms
were reviewed and approved by the McLean Hospital In-
stitutional Review Board. The participants were briefed
regarding the purpose and requirements of the study,
and then given time to read the informed consent form
in detail. After an opportunity to ask questions and
ensure understanding, written informed consent was
obtained. The participants underwent a physical examin-
ation by a physician and a mental health examination,
including a Structured Clinical Interview according to
DSM-IV criteria (SCID) [14], under the supervision of a
clinical psychologist. The inclusion criteria for participa-
tion consisted of being physically healthy, having no
Axis I psychological disorder (i.e., serious mental dis-
order such as major depression, bipolar disorder, or
schizophrenia), and meeting dependence criteria for ei-
ther cocaine or cannabis. Dependence was assessed dur-
ing the SCID by evaluating whether a maladaptive
pattern of substance use was occurring. Specifically, the
interviewer evaluated each participant for tolerance,
withdrawal, loss of control, preoccupation with obtaining
and using the drug, impacts on social, occupational, or
recreational activities, and use despite physical harm.
Individuals were excluded from participation if they had
abnormal blood and urine chemistry values, had an ab-
normal electrocardiogram, were taking prescription
medications, or had a history of head trauma or major
head injury. Four individuals did not qualify after the
physical examination and mental health assessments,
and two were excluded from the data analysis because
they did not report any drug use during the baseline
period. Of the remaining 20 participants who completed
the study (11 men, 9 women; mean age, 33.2±9.2 years;
age range, 21 – 49 years), nine met the criteria for co-
caine dependence (three crack cocaine users) and 11
met the criteria for cannabis dependence. The indivi-
duals were paid for their participation.
Equipments
TEAS was delivered by a Han’s Acupoint Nerve Stimula-
tor (HANS) (Hans International Inc., China). This
battery-operated device delivered electrical stimulation
via two pairs of outputs to electroconductive pads
placed at acupoints used in previous studies of heroin
addiction and treatment of withdrawal [10,11,15]. Dr. Ji-
Sheng Han, the developer of the HANS device, person-
ally trained the research staff to use the device and pro-
vided advice for the frequencies, durations, and
placements to be used based on his extensive work in
the field [12,16,17]. Acupoints are shown in Figure 1 and
are described in more detail below. The stimulation
comprised alternating 3-second intervals of pulses at fre-
quencies of 2 and 100 Hz using intensities that were suf-
ficiently strong to elicit a slight, but noticeable, twitch in
the index finger or thumb of each hand. The mean in-
tensity for the PC-6/TH-5 acupoint was 9.5±1.7 mA
(range, 5.7 – 12.7 mA), while that for the LI-4/PC-8 acu-
point was 12.6±3.0 mA (range, 7.7 – 18.1 mA). For the
sham stimulation, the participants received stimulation
at detectable threshold levels (approximately one-half of
the ‘twitch’ levels) for 2 minutes, followed by stimulation
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minutes of the session. The delivered current levels were
concealed from the participants.
Brain electroencephalographic (EEG) recordings of
evoked potentials were acquired using an Electro-Cap
(Electro-Cap International, USA) with 32 tin scalp elec-
trodes and two electro-oculographic electrodes. The
scalp electrodes were positioned in accordance with the
10–20 convention [18], affixed to the scalp with Electro-
Gel (Electro-Cap International), and referenced to a nose
electrode to create reference-free images. The interelec-
trode impedances were<10 kOhms at 30 Hz with on-
line wide bandpass filtering of 0.001 – 100 Hz and a
gain of 20,000 (EPA-6 Electrophysiology Amplifiers; Sen-
sorium Inc., USA).
Procedures
The study was a single-blind, sham-controlled, crossover
design. The participants were told that the study was
being conducted to assess the effects of different levels
of electrical stimulation on drug use and drug cravings,
and that they may or may not feel the stimulation.
Treatment
Following a baseline week during which the participants
recorded their drug use and drug cravings in daily diar-
ies, two 3.5-day treatment periods were conducted with
a 2-week ‘wash-out’ period between the two periods
(Table 1). In the diaries, the participants indicated their
drug use and rated their drug cravings on a scale of 0
(none at all) to 10 (extreme). In addition, they rated
themselves on seven items, comprising mood, concen-
tration, appetite, sleep quality, anxiety, irritability, and
tension/agitation, using a 100-mm visual analog scale.
The order of the TEAS and sham stimulation treatments
was counterbalanced among the participants. The treat-
ment periods consisted of two 30-minute sessions of stimu-
lation (separated by 3 to 6 hours )p e rd a yf o r3c o n s e c u t i v e
Figure 1 Acupoints for electrical stimulation with the HANS device were located by visual inspection, measurement, and palpation of
the participant’s hands and forearm/wrist. Four acupoints were stimulated: PC-6 (Neiguan), 2 inches (i.e. 2 cun) proximal of the palm, between
the palmaris longus tendon and flexor carpi radialis tendon; TH-5 (Waiguan), 2 inches (i.e. 2 cun) proximal of the skin crease on the back of the
wrist, between the ulnar and radius bones; LI-4 (Hegu), at the midpoint of the second metacarpal bone on the radial side; and PC-8 (Laogong),
midway between the second and third metacarpal on the palmar side.
Table 1 Summary of procedure. Treatment periods were either with sham stimulation or active current presented in a
counterbalanced order across subjects
Study phase Events Notes
Baseline period Daily diaries for drug use and cravings Recorded for 1 week
Treatment 1 Two 30-minute sessions for 3 1/2 days Sessions separated by 3 to 6 hours
Cue-induced craving
EEG session
Event-Related Potential (ERP) recordings
following neutral and drug-related cues
Session began 1 hour after last
Transcutaneous Electric Acupoint
Stimulation (TEAS) treatment
Washout period 2 weeks in length No treatments; continue to record
drug use and cravings in diaries
Treatment 2 Two 30-minute sessions for 3 1/2 days Sessions separated by 3 to 6 hours
Cue-induced craving
EEG session
Event-Related Potential (ERP) recordings
following neutral and drug-related cues
Session began 1 hour after last
Transcutaneous Electric Acupoint
Stimulation (TEAS) treatment
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a final 30-minute session of stimulation, followed by a cue-
induced craving EEG evaluation after 1 hour.
Electroconductive pad placement
At each treatment session, the four specific acupoints
for placement of the electroconductive pads of the
HANS stimulation device were located by visual inspec-
tion, measurements, and palpation of the participant’s
hands and forearms/wrists. The targeted acupoints were
as follows (Figure 1): PC-6 (Neiguan), 2 inches (i.e. 2
cun) proximal to the palm between the palmaris longus
tendon and flexor carpi radialis tendon; TH-5 (Wai-
guan), 2 inches (i.e. 2 cun) proximal to the skin crease
on the back of the wrist between the ulna and radius
bones; LI-4 (Hegu), at the midpoint of the second meta-
carpal bone on the radial side; and PC-8 (Laogong), mid-
way between the second and third metacarpals on the
palmar side.
EEG recordings
The cue-induced craving EEG evaluation investigated
brain event-related potentials (ERPs) and specifically
probed the production of the P300 wave response while
the participants viewed photographs of objects from
three categories: neutral (furniture such as chairs, lamps,
baskets); non-drug-related arousing (shark attack,
pointed gun, ferocious barking dog); and drug-related.
The drug-related photographs were specific to the parti-
cipant’s drug of choice (scenes of drug paraphernalia and
drug use). An oddball visual procedure presented the
images in a pseudorandom order using the following
proportions: 60% common/frequent neutral pictures and
40% target/rare pictures (20% drug-related and 20%
arousing). Two successive rare images were never pre-
sented. The images were displayed for 750 ms at 1-
second intervals. The participants were asked to differ-
entiate between drug scenes and non-drug scenes (neu-
tral or arousing) by pressing a corresponding button on
a computer mouse. The first EEG/ERP session was con-
ducted after a short acclimation period in the recording
chamber. A second EEG/ERP session was conducted 26
minutes later, after the participants had handled neutral
objects such as common office items (e.g., pens, paper,
staplers) for 7 minutes. A third EEG/ERP session was
conducted 26 minutes later, after the participants had
handled drug-related objects (e.g., drug paraphernalia).
The cocaine-dependent participants were allowed to
handle paraphernalia associated with smoked (crack) or
snorted cocaine. The cannabis-dependent participants
were allowed to handle and smell a used pipe that con-
tained residual byproducts of burned marijuana. At four
times during the ERP sessions, the participants answered
two questions of “Would you use cocaine (or marijuana)
now if you could?” (Yes/No) and “What is your desire to
use cocaine (or marijuana) right now?”. The responses
to the latter question were evaluated using a 100-mm
visual analog scale from ‘none at all’ to ‘extreme’.
Regarding the timing, the questions were asked before
and after the participants handled the neutral objects be-
fore the second EEG/ERP session, and before and after
the participants handled the drug-related objects before
the third EEG/ERP session.
Data analysis
ERPs were analyzed using Brain Vision Analyzer version
1.05.0004 (Brain Products GmbH, Germany). The pro-
cessing included screening for artifacts, filtering (Butter-
worth zero phase, cutoff=40 Hz, slope=48 dB/oct), and
ocular correction, 10 automated artifact rejections, and
baseline correction. The trials for each picture type
(neutral, arousing, or drug-related) were averaged, and
the amplitude and latency to peak response of the P300
waveforms were identified for each participant based on
the largest positive peak between 300 and 600 ms. The
waveforms and P300 amplitudes showed no differences
between the left and right electrodes. Each participant’s
drug craving and drug use data were averaged across
days within each study phase before combination across
subjects.
The data were presented as the mean±standard devi-
ation (SD). Statistical analyses for all dependent mea-
sures were conducted with SPSS 13.0 for Mac OS X
(SPSS Inc., USA) using a linear mixed-effects model
repeated-measures one-way analysis of variance
(ANOVA). When appropriate, post hoc analyses of pair-
wise comparisons were conducted with Fisher’s least sig-
nificant difference test. Statistical significance for all tests
was set at P<0.05.
Results
Drug cravings and drug use during treatment
The participants provided daily overall ratings of their
cravings for cocaine or cannabis during the previous 24-
hour period, and self-reported their daily use of cocaine
or cannabis (Figure 2, Table 2). The self-reported crav-
ings averaged between 6 and 7 on a 10-point scale dur-
ing the baseline week before the treatments began.
These ratings did not change significantly during treat-
ment with either the TEAS or sham stimulation of the
acupoints. The cocaine-dependent participants reported
using cocaine twice a day on average, while the
cannabis-dependent participants used cannabis four
times a day on average. These rates of use were not sig-
nificantly altered by either treatment.
Penetar et al. Chinese Medicine 2012, 7:14 Page 4 of 10
http://www.cmjournal.org/content/7/1/14Mood measurements during treatment
The self-reported ratings for anxiety in both sets of par-
ticipants are shown in Figure 3. Overall, the cocaine-
dependent participants had higher ratings for anxiety
than the cannabis-dependent participants in all phases
of the study. TEAS treatment significantly reduced the
anxiety ratings in the cocaine-dependent participants (F
(2,16)=5.44, P=0.016). The daily ratings declined over
the treatment days (Figure 3, top right panel). Post hoc
analyses revealed that the mean ratings on day 4 of
TEAS treatment were significantly lower than those on
the baseline days. The ratings for anxiety in the
cannabis-dependent participants did not change signifi-
cantly during the treatment. Several additional measures
were significantly altered during the treatment (Table 3).
TEAS significantly reduced tension/agitation and irrit-
ability, and improved concentration in the cocaine-
dependent participants. Similarly, significant decreases
in tension/agitation and irritability were found in the
cannabis-dependent participants.
EEG findings
Analyses of the four central recording electrodes (Oz,
Pz, Cz, and Fz) were conducted in all participants. At
each electrode, the peak response voltage and latency to
peak response of the P300 waveform were analyzed.
Figures 4 and 5 show the summed ERP responses for
the four specific conditions of the study, comprising the
ERPs for viewing neutral and drug-related pictures
according to the treatment condition. These data were
collected during the third ERP session, in which the par-
ticipants handled drug-related paraphernalia before
viewing the pictures. The mean peak voltage values for
each condition are shown in the bar graphs accompany-
ing the ERP lines (values are presented in the Additional
Figure 2 Craving scores and daily use mean±SD by phase of the study for cocaine and marijuana participants. Cravings were ratings on
a 10-point scale from 1-‘none’ to 10-‘extremely’. ‘Baseline’ refers to assessments during the one week before any treatment was conducted. A:
Cocaine craving; B: Cocaine use; C: Marijuana craving; D: Marijuana use.
Table 2 Drug use and cravings during phases of the
study (mean±SD)
Mean±SD 95% confidence interval
Cocaine use
Baseline 1.22±1.1 [−0.34, 2.8]
Sham 0.9±1.3 [−0.58, 2.4]
TEAS 2.17±3.2 [0.69, 3.6]
Cocaine cravings
Baseline 6.7±2.8 [4.5, 8.9]
Sham 4.8±3.3 [2.7, 6.9]
TEAS 5.96±2.9 [3.8, 8.0]
Marijuana use
Baseline 4.6±2.7 [2.7, 6.4]
Sham 4.9±2.7 [3.4, 6.5]
TEAS 4.6±2.2 [3.1, 6.2]
Marijuana cravings
Baseline 6.8±1.8 [5.7, 7.9]
Sham 7.1±1.1 [6.2, 8.2]
TEAS 6.3±1.7 [5.4, 7.4]
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participants (Figure 4), there was a main effect for pic-
ture type, and the responses to the neutral pictures were
lower than the responses to the drug pictures for Oz (F
(5,40)=2.749, P=0.032), Pz (F(5,40)=7.105, P<0.001),
and Cz (F(5,40)=2.809, P=0.029). The responses to the
drug-related pictures recorded at Fz did not differ sig-
nificantly from the responses to the neutral pictures.
There was no effect of TEAS treatment, since the
responses to the drug-related pictures and neutral pic-
tures did not differ significantly following the TEAS and
sham stimulation treatments. For the cannabis-
dependent participants (Figure 5), the responses did not
differ significantly by treatment or picture type. In both
groups of participants, post hoc analyses revealed that
the responses to the non-drug-related arousing pictures
differed significantly from those to the neutral pictures,
but did not differ significantly from the responses to the
drug-related pictures (data not shown).
The latencies to peak responses were not altered by
the treatment or picture type for three of the center line
electrodes, Pz, Cz, and Fz (values presented in the Add-
itional file 1: Supplemental tables). For Oz, however, the
latency to peak response was longer for the drug-related
pictures than for the neutral pictures in both the
cocaine-dependent (F(5,40)=6.797, P<0.001) and
cannabis-dependent (F(5,50)=6.104, P<0.001) partici-
pants. In a similar manner to the peak response results,
post hoc analyses revealed that the latency measures for
the ERP responses to the non-drug-related arousing pic-
tures differed from those to the neutral pictures, but did
not differ from the responses to the drug-related
pictures.
Response to cue-induced craving questions
The responses to the question “Would you use cocaine
(or marijuana) now if you could?” did not vary systemat-
ically during the ERP session within each group of parti-
cipants. Overall, the cocaine-dependent participants
reported that they would use the drug now if they could
Figure 3 Ratings of anxiety during each phase of the study for cocaine and marijuana participants. Anxiety was rated on a 100 mm line
with anchors of ‘none’ to ‘extremely’. Left panels are group mean±SD; right panels are individual participant scores (averaged during Baseline
and Sham, but by separate days during TEAS treatment).* significantly different from baseline, P<0.05. A: Anxiety of cocaine subjects; B: Anxiety
of marijuana subjects.
Table 3 Ratings on 100 mm visual analog scales during
phases of study (mean±SD)
Baseline Sham TEAS
Cocaine
Anxiety 58.9±12.7 53.2±7.6 42.4±16.1* P=.007
Mood 44.4±24.9 60.5±20.4 56.2±21
Concentration 45.7±22.4 60±22.1 59.6±17.6* P=.045
Appetite 44.3±19.5 53.3±13.2 54.8±21
Sleep quality 50.8±25.5 59.2±19.8 54.9±28.3
Irritability 53.7±16.5 46.4±7.2 34.6±21.6* P=.047
Tension & agitation 50.1±17.7 32.8±17.5 23.7±17.2* P=.0004
Marijuana
Anxiety 26.3±14.2 29.1±18.4 25.9±23.5
Mood 48.8±14.9 55.2±18.4 54.1±21.2
Concentration 54.2±20.8 55.5±24.1 59.8±22.8
Appetite 43.7±16.2 45.2±22.8 49.5±17.8
Sleep quality 69.3±14.9 63.6±22.1 64.3±21.1
Irritability 32.0±18.8 29.1±18.2 22.3±17.8* P=.05
Tension & agitation 26.5±21.1 23.2±19.1 12.0±13.2* P=.05
*Significantly different from Baseline.
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pants said ‘yes’ 94% of the time. The responses to the
question “What is your desire to use cocaine (or
marijuana) right now?” displayed a similar difference be-
tween the groups, with mean scores of 26 for the
cocaine-dependent participants and 63 for the cannabis-
dependent participants on a scale of 0 to 100.
Discussion
The technique of applying electrical stimulation to spe-
cific acupoints on the body to alter cocaine or cannabis
use or cravings has not previously been evaluated. The
results of the present pilot study suggest that TEAS does
not cause robust changes in measures of drug use and
daily drug cravings in cocaine- and cannabis-dependent
participants who were not seeking treatment for their
dependence. Neither drug use nor drug cravings were
significantly decreased during 3.5 days of TEAS
treatment. However, several interesting changes in other
mood states were revealed, which may collectively play a
role in drug abuse treatment strategies. Several ratings
in the daily mood assessments were reduced in the
cocaine- and cannabis-dependent participants, and the
response to the drug-related pictures during the EEG as-
sessment in the cocaine-dependent participants showed
a nominal, but not statistically significant, reduction fol-
lowing TEAS treatment.
We analyzed the EEG/ERP P300 profiles for peak ampli-
tude and latency to peak response with particular interest
in the responses to drug-related cues for cocaine or can-
nabis. The altered peak voltage of the P300 EEG/ERP re-
sponse in the cocaine-dependent participants may
indicate a reduced response to drug-related cues. Despite
a lack of statistical significance, the reduction in the P300
ERP amplitudes during the presentation of cocaine cues in
the cocaine-dependent participants was consistent and
Figure 4 Averaged ERP for four conditions in cocaine abusing subjects (n=9). Red lines and bars represent averaged responses to neutral
pictures after sham TEAS treatment; Blue lines and bars represent responses to neutral pictures after active TEAS treatment; Black lines and bars
represent responses to drug pictures after sham TEAS treatment; Green lines and bars represent responses to drug pictures after active TEAS
treatment. Bar graph inserts show magnitude of peak response in μV (mean±SD) averaged across subjects. * indicates significant differences
between responses to drug pictures and neutral pictures (P<0.05). + indicates a statistical trend (P=0.06). A: Oz; B: Pz; C: Cz; D: Fz.
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tively short duration of TEAS treatment in the present
study. Although subjective drug cravings and drug use in
the cocaine-dependent participants was not reduced by
TEAS treatment, examination of the subjective mood
assessments in the cocaine-dependent participants
revealed that TEAS treatment led to significant reductions
in self-reports of anxiety, tension/agitation, and irritability,
while concentration was improved. The present examin-
ation of the effects of TEAS treatment on cannabis cue re-
activity and cravings assessed by the EEG/ERP P300
profiles for peak amplitude and latency to peak response
in the cannabis-dependent participants did not reveal
altered responses to cannabis-related cues. Similarly, sub-
jective cannabis craving and self-reported use did not
change as a result of TEAS treatment in the cannabis-
dependent participants. TEAS treatment resulted in sig-
nificant reductions in irritability and tension/agitation in
the cannabis-dependent participants. These changes in
the mood ratings may be of particular interest for canna-
bis dependence, because changes in these measures were
previously identified as hallmarks of cannabis withdrawal
during early abstinence [19]. Collectively, the findings in-
dicate that TEAS treatment did not result in robust reduc-
tions in the EEG/ERP cue reactivity to drug-related
pictures in either the cocaine- or cannabis-dependent par-
ticipants. However, the observed reductions in negative
mood measures resulting from TEAS treatment may have
direct relationships with the modest reductions in drug
cue reactivity observed for cocaine dependence. Improve-
ments in these behavioral events may be useful in treat-
ment settings, as previously noted by Meade et al. [20].
These authors previously demonstrated that, in addition
to positive effects of TEAS as an adjunct treatment, there
were marked improvements in mental health and self-
reported physical health as a result of TEAS treatment
Figure 5 Averaged ERP for four conditions in marijuana abusing subjects (n=11). Red lines and bars represent averaged responses to
neutral pictures after sham TEAS treatment; Blue lines and bars represent responses to neutral pictures after active TEAS treatment; Black lines and
bars represent responses to drug pictures after sham TEAS treatment; Green lines and bars represent responses to drug pictures after active TEAS
treatment. Bar graph inserts show magnitude of peak response in μV (mean±SD) averaged across subjects. A: Oz; B: Pz; C: Cz; D: Fz.
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follow-up period after inpatient opiate detoxification.
Several limitations of our study should be noted. The
first is the duration of the assessment period for drug
use, particularly for the cocaine-dependent participants.
Significant alterations in cocaine use may not be observ-
able during a 3-day assessment period. Since cocaine use
is typically episodic and highly variable from day to day
in many cocaine abusers [4,21], a true assessment of use
may require several weeks. The brief drug-use assess-
ment period would not appear to be a limitation for the
cannabis-dependent subjects, because their use was
regular and multiple times per day. Second, for practical
reasons and equipment limitations, our treatments in
this outpatient study were only administered twice a
day, and only separated by 3 to 4 hours. Although
changes in brain endogenous opioid levels have been
observed from minutes to 1 hour after stimulation [1]
and the effects on cocaine place preference can last for
24 hours [12], a proposal of three treatments per day
separated by approximately 6 hours may be the most ef-
fective way to produce a maximal and sustained neuro-
chemical alteration (Dr. Ji-Sheng Han, personal
communication). Hence, there may be differential effects
of TEAS treatment administered three times a day at 6
hours apart, compared with our TEAS treatment deliv-
ered only twice a day at 3 to 4 hours apart. Similarly,
while a previous study of opioid dependence demon-
strated positive effects of TEAS treatment using a simi-
lar number of TEAS treatment days [20], more robust
findings from studies on opioids and positive findings
for other drugs of abuse may result from TEAS periods
with a greater number of treatment days. Third, the
present study used alternating stimulation at 2 and
100 Hz. Although this method reliably increases en-
dogenous opioids that activate mu, sigma, and kappa
opioid receptors [13], antagonism of the effects of co-
caine within the opioid system may primarily rely on the
activation of kappa receptors. Ren et al.[12] showed that
stimulation at 100 Hz, which acts primarily on kappa
receptors, caused increases in the dynorphin levels and
was effective for attenuating cocaine-induced condi-
tioned place preference in rats. Finally, we chose to re-
cruit individuals who were not seeking treatment for
their dependence as a more rigorous test of the proced-
ure. Additional studies will be needed to address these
limitations, increase our sample size, and adjust the ex-
perimental protocols to explore the potential efficacy of
TEAS on cocaine and cannabis use and cravings.
Conclusion
Pharmacological and alternative medicine treatments for
cocaine and cannabis abuse have not been developed to
date. The present results suggest that the TEAS protocol
used in this trial alone is not sufficient to significantly
alter cocaine and cannabis use, drug cue reactivity, or
drug cravings in cocaine- or cannabis-dependent indivi-
duals who are not seeking treatment for their depend-
ence. However, it may be premature to state TEAS
treatment is ineffective for use in cocaine or cannabis
dependence, until TEAS treatment has been evaluated
under a range of parameters, including longer treatment
durations and different frequencies, and the contribu-
tion, if any, to reductions in negative moods can be
assessed. Future assessments will need to evaluate the
ability of TEAS to contribute to more comprehensive
treatment regimens.
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